Abstrakt

Telemedicine for Intravitreal Bevacizumab Infusion in the Stanford College Organization for Determination of Retinopathy of Rashness (SUNDROP) Companion

Ibrahim Shah

Telemedicine has arisen as a possible answer for face the disparity between babies that should be evaluated for retinopathy of rashness (ROP) and the absence of ophthalmologists. We assessed its utility in the development after off-name intravitreal infusion of bevacizumab. None of the treated babies wound up with awful anatomic result. Telemedicine is an elective safe strategy to screen patients after treatment.